Physician profile
John H Mitchell
NPI 1699781674
$3,939.22
in general payments reported to CMS, 2019-2025
13 companies · $1,589 in 2025
The $1,589 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $198 · 2020: $1,280 · 2021: $21.20 · 2022: $335 · 2023: $262 · 2024: $254 · 2025: $1,589.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,462 · Food and Beverage: $643.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,461.84 |
| Food and Beverage | $643.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bolton Medical INC | $1,461.84 | 2025 | |
| Boston Scientific Corporation | $952.32 | 2020 | |
| Edwards Lifesciences Corporation | $514.16 | 2019-2025 | |
| Abiomed | $288.10 | 2019-2023 | Impella |
| Medtronic Vascular, INC. | $286.98 | 2020 | |
| Abbott Laboratories | $170.85 | 2022-2024 | Portico |
| Medtronic, INC. | $136.52 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $40.63 | 2020 | |
| Zimmer Biomet Holdings, INC. | $25.82 | 2022 | |
| Atricure, INC. | $17.96 | 2025 | Atriclip Laa Exclusion System, Synergy Ablation System, Atricure Cryoice Cryoablation System (Cryo2) |
| Ethicon US, LLC | $16.28 | 2022 | |
| Janssen Pharmaceuticals, INC | $14.65 | 2021 | |
| Medical Device Business Services, INC. | $13.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Mitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.